Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-11-24

Posted on November 24, 2025August 8, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-11-24

Fact Source: Financial Supervisory Service DART

💡 Executive Summary

Hanwha Ocean secured a major contract worth KRW 757.7B (7.0% of recent annual revenue) to construct four Very Large Crude Carriers (VLCC) for an African shipowner.

📊 [Key Disclosure Details & Financial Summary]

1. Contract Overview

  • Contract Type: Construction Order
  • Contract Name: 4 Very Large Crude Carriers (VLCC)

2. Financial Details & Scale

  • Contract Amount: KRW 757,700,000,000 (KRW 757.7B / approx. USD 516.0M equivalent)
    • Applied FX Rate: USD/KRW = 1,468.40 (Base rate on 2025-11-21, rounded at 100M KRW)
  • Recent Revenue: KRW 10,776,000,000,000 (KRW 10.776T, FY2024 consolidated basis)
  • Ratio to Revenue: 7.0%
  • Contracting Party & Relationship: African Shipowner (No special relationship)
  • Sales/Supply Region: Africa Region

3. Contract Terms & Schedule

  • Contract Period: 2025-11-21 ~ 2028-11-30
  • Contract Date: 2025-11-21
  • Key Terms: Down payment/advance payment included / Payment collected according to construction progress

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Monitoring Vessel Construction Progress and Revenue Recognition

This filing discloses that Hanwha Ocean entered into a KRW 757.7B contract with an African shipowner to build four VLCCs.

Verifying that payments are collected according to progress and that construction proceeds as scheduled over the contract period (November 21, 2025 – November 30, 2028) is important for evaluating whether revenue from this large-scale order is recognized as planned.

Progress regarding order backlog and construction status can be tracked through future official periodic filings, such as Quarterly, Semi-Annual, and Annual Reports.

📢 Disclaimer & Source Notice

Source: This content was newly structured and generated based on official filing data from the Financial Supervisory Service DART system.

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Shipbuilding

Post navigation

Previous Post: [Disclosure] Hanwha Ocean (042660) – Paid-in Capital Increase Decision / 2025-11-24
Next Post: [Disclosure] Samsung Biologics (207940) – Information Disclosure / 2025-11-24

Related Posts

[Disclosure] Hanwha Aerospace (012450) to Host Investor Relations (IR) Event for Domestic and Overseas Institutional Investors in Seoul on May 19, 2025 Disclosures
[Disclosure] Hanwha Systems (272210) – Change in Completion Date for KRW 125.0B Supply Contract with Naval Logistics Command (Extended to August 31, 2026) Disclosures
[Disclosure] Hanwha Aerospace (012450) – Board Resolution to Convene 47th Annual General Meeting of Shareholders (Proposed Cash Dividend of KRW 1,800 per Share / Scheduled for March 26, 2024) Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2025-09-09 Semiconductors
[Disclosure] HPSP (403870) – Setting of Record Date or Closure of Register of Shareholders / 2025-08-07 Disclosures
[Disclosure] Celltrion (068270) – Consolidated Financial Results (Provisional Earnings Release) / 2026-05-06 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme